119-OR: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Ultra-Long-Acting GLP-1 Receptor Agonist (ZT002) in Healthy Subjects
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-05-07 15:07:36 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.2337/db24-119-or
其他信息:
出版社: American Diabetes Association
作者: YUANYUAN ZHANG; XIUSEN XU; KRISTI MCLENDON; ALEX H.L. WONG; YUYING ZHANG; XUJIA ZHANG
全文下载地址: https://diabetesjournals.org/diabetes/article/73/Supplement_1/119-OR/155504/119-OR-Safety-Tolerability-Pharmacokinetics-and